Cefarka 250mg Injection
Marketer
Mediarka Lifesciences Pvt Ltd
Salt Composition
Ceftriaxone (250mg)
Overview Cefarka 250mg Injection
Cephalosporin antibiotic Cefarka 250mg Injection combats bacterial infections throughout the body. Its applications span diverse infections, including those affecting the brain (meningitis), lungs (pneumonia), ears, urinary tract, skin and soft tissues, bones and joints, bloodstream, and heart. Prophylactically, it can also prevent surgical site infections. Administered intravenously (drip) or by intramuscular/intravenous injection by a healthcare professional, dosage is determined by your physician. Consistent, evenly spaced doses, as directed, are crucial; completing the prescribed course is essential to prevent infection recurrence or exacerbation. Common side effects – diarrhea, rash, altered liver function tests, and blood cell count variations (e.g., eosinophilia, leukopenia, thrombocytopenia) – are usually mild. Injection site redness or pain may also occur. Report persistent or bothersome side effects to your doctor. Prior to treatment, disclose any antibiotic allergies, kidney or liver issues, and all other medications you are currently using to your doctor, as drug interactions are possible.
Uses of Cefarka 250mg Injection
Managing Bacterial Infections
Major Benefits of Cefarka 250mg Injection:
Administering this medication requires a healthcare professional; please do not attempt self-medication.
Common Side effects of Cefarka 250mg Injection:
- Diarrhea
- Abnormal liver function tests
- Rash
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count
- Low blood platelets
How to use Cefarka 250mg Injection:
Administering this medication will be performed by your physician or their qualified assistant; self-medication is strictly prohibited.
How Cefarka 250mg Injection works:
Cefarka 250mg injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, thereby preventing bacterial survival.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Cefarka 250mg Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
Administration of Cefarka 250mg Injection during gestation appears safe. The preponderance of research indicates minimal to negligible fetal risk.
Breast feedingCAUTION
Administering Cefarka 250mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Cefarka 250mg Injection might induce drowsiness, blurred vision, or dizziness. Driving should be avoided if such effects are experienced.
KidneySAFE IF PRESCRIBED
Cefarka 250mg Injection can be administered to patients with impaired renal function without altering the dosage. Nevertheless, disclosure of pre-existing kidney conditions to the prescribing physician is advised.
LiverCAUTION
Cefarka 250mg Injection requires careful administration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Cefarka 250mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefarka 250mg Injection :
Omitting a scheduled dose of Cefarka 250mg Injection warrants contacting your physician.
Facts to Know About Cefarka 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently